Furthermore, these authors showed that oral treatment of the Akita mouse model of diabetes with a NRF2 activator, dh404 (3 mg/kg daily), upregulated NRF2‐responsive genes and cytoprotective enzymes and improved vascular relaxation of aortic rings in vitro. The gene discussed is NFE2L2; the disease is diabetes mellitus.